The rapid outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused the ongoing coronavirus disease…
View More Instrument to measure risk of reverse zoonotic SARS-CoV-2 transmission events from humans to animalsHome » Coronavirus Disease COVID-19 »
Universal screening for SARS-CoV-2 among hospitalized patients may be ineffective
A new preprint shows that universal screening of all hospital admissions for infection with the…
View More Universal screening for SARS-CoV-2 among hospitalized patients may be ineffectiveStudy reveals why SARS-CoV-2 is more infectious than SARS-CoV-1
Coronaviruses such as the severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 are enveloped positive-sense…
View More Study reveals why SARS-CoV-2 is more infectious than SARS-CoV-1Scientists simulate SARS-CoV-2 virion envelope using Martini 3
A new study published on the preprint server bioRxiv* proposes an integrative computational approach to…
View More Scientists simulate SARS-CoV-2 virion envelope using Martini 3A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2
Scientists believe that vaccinating the entire global population is the key to contain the ongoing…
View More A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2As COVID restrictions were removed, Texas saw an increase in seasonal respiratory virus infections
Like many US states, Texas introduced many different measures to reduce the transmission of severe…
View More As COVID restrictions were removed, Texas saw an increase in seasonal respiratory virus infectionsmRNA COVID-19 vaccine protection wanes after six months: a wide-scale study of the population of Qatar
Immunization against COVID-19 began in Qatar in December 2020, with the Pfizer-BioNTech and then Moderna…
View More mRNA COVID-19 vaccine protection wanes after six months: a wide-scale study of the population of QatarPotential variant of interest in South Africa assigned to the PANGO lineage C.1.2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease…
View More Potential variant of interest in South Africa assigned to the PANGO lineage C.1.2Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine
In March 2020, the World Health Organization declared the rapid spread of severe acute respiratory…
View More Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccineNext-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice
Researchers in Canada have developed an adenoviral vector-based vaccine against coronavirus disease 2019 (COVID-19) that…
View More Next-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice